Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Byrne MT"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Roboz GJ; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine and the New York-Presbyterian Hospital, New York, NY., Sanz G; Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe,Valencia, and CIBERONC Cáncer, Instituto de Salud Carlos III, Madrid, Spain., Griffiths EA; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Yee K; Department of Medicine, Princess Margaret Cancer Centre, Toronto, ON, Canada., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Récher C; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Byrne MT; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Patkowska E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Kim HJ; Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Thomas X; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Moors I; Department of Hematology, Universitair Ziekenhuis Gent, Ghent, Belgium., Stock W; Department of Medicine, The University of Chicago Medical Center, Chicago, IL., Illés Á; Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Fenaux P; Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris and Université Paris Cité, Paris, France., Miyazaki Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan., Yamauchi T; Department of Hematology, University of Fukui Hospital, Eiheiji-chō, Japan., O'Connell CL; Keck School of Medicine of USC, Los Angeles, CA., Hao Y; Astex Pharmaceuticals, Inc, Pleasanton, CA., Keer HN; Astex Pharmaceuticals, Inc, Pleasanton, CA., Azab M; Astex Pharmaceuticals, Inc, Pleasanton, CA., Döhner H; Department of Internal Medicine, Ulm University Hospital, Ulm, Germany.
Publikováno v:
Blood advances [Blood Adv] 2024 Apr 23; Vol. 8 (8), pp. 2020-2029.
Autor:
Mishra A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Tamari R; Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Byrne MT; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Gooptu M; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Chen YB; Hematopoietic Cell Transplant and Cell Therapy Program, Massachusetts General Hospital, Boston, MA., Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Sallman D; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Gallacher P; Aprea Therapeutics, Boston, MA., Wennborg A; Aprea Therapeutics, Boston, MA., Hickman DK; Aprea Therapeutics, Boston, MA., Attar EC; Aprea Therapeutics, Boston, MA., Fernandez HF; Moffitt Cancer Center, Pembroke Pines, FL.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Dec 01; Vol. 40 (34), pp. 3985-3993. Date of Electronic Publication: 2022 Jul 11.
Autor:
Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mehraban N; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Baer B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Long N; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Jayani RV; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Byrne MT; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kassim AA; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Engelhardt BG; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Savani BN; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Oluwole OO; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Sep; Vol. 198 (6), pp. 1073-1075. Date of Electronic Publication: 2022 Jun 28.
Autor:
Merryman RW; Division of Hematologic Malignancies and., Redd RA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Chavez J; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Darrah JM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.; Cedars-Sinai Medical Center, Los Angeles, CA., Rao U; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Byrne MT; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Bond DA; Division of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Hospital, Columbus, OH., Maddocks KJ; Division of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Hospital, Columbus, OH., Spinner MA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Ballard HJ; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Svoboda J; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Singh AK; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS., McGuirk JP; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS., Modi D; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI., Ramchandren R; Division of Hematology/Oncology, University of Tennessee School of Medicine, Knoxville, TN., Romancik J; Department of Hematology and Medical Oncology, Emory University-Winship Cancer Institute, Atlanta, GA., Cohen JB; Department of Hematology and Medical Oncology, Emory University-Winship Cancer Institute, Atlanta, GA., Frigault MJ; Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA., Chen YB; Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA., Serritella AV; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Kline J; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Ansell S; Division of Hematology, Mayo Clinic, Rochester, MN., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL., Rahimian M; Beth Israel Deaconess Medical Center, Boston, MA., Joyce RM; Beth Israel Deaconess Medical Center, Boston, MA., Shah M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., David KA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Park S; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC., Beaven AW; Division of Hematology, University of North Carolina, Chapel Hill, NC., Habib A; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Nakhoda S; Division of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA; and., Khan N; Division of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA; and., Lynch RC; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Smith SD; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Ho VT; Division of Hematologic Malignancies and., LaCasce A; Division of Hematologic Malignancies and., Armand P; Division of Hematologic Malignancies and., Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Publikováno v:
Blood advances [Blood Adv] 2021 Mar 23; Vol. 5 (6), pp. 1648-1659.
Autor:
Mangan BL; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA., Patel D; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Chen H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Gatwood KS; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA., Byrne MT; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Sengsayadeth S; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Goodman S; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Dholaria B; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Kassim AA; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Jagasia M; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Chinratanalab W; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Culos KA; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA., Engelhardt BG; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Publikováno v:
EJHaem [EJHaem] 2020 Nov; Vol. 1 (2), pp. 576-580. Date of Electronic Publication: 2020 Sep 23.
Autor:
Gandelman JS; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN.; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN., Byrne MT; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN., Mistry AM; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN., Polikowsky HG; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN., Diggins KE; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN., Chen H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Arora M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Cutler C; Stem Cell/Bone Marrow Transplantation Program, Dana-Farber Cancer Institute, Boston, MA., Flowers M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Pidala J; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Irish JM; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN jonathan.irish@vanderbilt.edu madan.jagasia@vanderbilt.edu.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN., Jagasia MH; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN jonathan.irish@vanderbilt.edu madan.jagasia@vanderbilt.edu.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.
Publikováno v:
Haematologica [Haematologica] 2019 Jan; Vol. 104 (1), pp. 189-196. Date of Electronic Publication: 2018 Sep 20.
Autor:
Gatwood KS; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA. katie.s.gatwood@vanderbilt.edu., Culos KA; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA., Binari LA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Engelhardt BG; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Kassim A; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Byrne MT; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Goodman SA; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Chinratanalab W; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Sengsayadeth SM; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Greer JP; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Jagasia M; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2018 Jun; Vol. 53 (6), pp. 795-799. Date of Electronic Publication: 2018 Mar 14.
Autor:
Johnpulle RA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Paczesny S; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana., Jung DK; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Daguindau E; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana., Jagasia MH; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Savani BN; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Chinratanalab W; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Cornell RF; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Goodman S; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Greer JP; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Kassim AA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Sengsayadeth S; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Byrne MT; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Engelhardt BG; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: brian.engelhardt@vanderbilt.edu.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2017 Mar; Vol. 23 (3), pp. 529-532. Date of Electronic Publication: 2016 Dec 21.